Mini optical fiber device may boost cancer treatment success

Nov. 24, 2021
The technology—a miniaturized implantable device that employs electrode-embedded optical fibers—offers local delivery of medication as well as measurement of tumor impedance and monitoring of the drug’s efficacy over the course of several weeks.

Existing challenges make it difficult for oncologists to ensure “more than moderate success” of cancer immunotherapy. To date, delivery methods do not allow medications to be adjusted “either to lower systemic toxicities or to augment therapeutic response.” Now, researchers are aiming to overcome those hurdles with a miniature optical fiber device.

Developed by a team at Virginia Tech (Blacksburg, VA), the technology — a miniaturized implantable device that employs electrode-embedded optical fibers — offers local delivery of medication as well as measurement of tumor impedance and monitoring of the drug’s efficacy over the course of several weeks. According to the study, published in Nature Communications the combination of local immune checkpoint blockade [antibody] delivery via this device with photodynamic therapy elicits a sustained anti-tumor immunity in multiple tumor models.”

In their work, the researchers injected tumor cells into mice that had been cured of cancer — this allowed them to test the animals’ immune memory against tumors. The team found no tumor regrowth in any of the cured mice. Measuring tumor electrical signals via the new device is done rapidly and allows real-time monitoring of tumor growth; it also “avoids antibodies causing toxicities before reaching the tumor.”

“We can infuse antibodies through our miniature fiber to the tumor to activate T cells around tumor cells and further elicit anti-tumor immunity by recruiting more T cells to the tumor bed,” says researcher Xiaoting Jia, an assistant professor in Virginia Tech’s Bradley Department of Electrical and Computer Engineering. “This will eventually produce strong and durable anti-tumor immunity as we see the accumulated memory T cells in tumors and lymph nodes.”

About the Author

Justine Murphy | Multimedia Director, Digital Infrastructure

Justine Murphy is the multimedia director for Endeavor Business Media's Digital Infrastructure Group. She is a multiple award-winning writer and editor with more 20 years of experience in newspaper publishing as well as public relations, marketing, and communications. For nearly 10 years, she has covered all facets of the optics and photonics industry as an editor, writer, web news anchor, and podcast host for an internationally reaching magazine publishing company. Her work has earned accolades from the New England Press Association as well as the SIIA/Jesse H. Neal Awards. She received a B.A. from the Massachusetts College of Liberal Arts.

Sponsored Recommendations

Spherical Lenses: Precision for Your Optics Needs

March 13, 2025
Discover the versatility of spherical lenses for your optical applications. Learn how Lacroix Optics ensures high precision for optimal performance across various industries.

Optical Windows & Wedges: Enhance Your Optical Systems

March 13, 2025
Explore Lacroix Optics’ selection of optical windows and wedges, designed to deliver superior clarity and performance for your applications.

Optical Assemblies: Reliable and Precise Solutions

March 13, 2025
Ensure your optical system works seamlessly with Lacroix Optics' custom optical assemblies. Discover the precision and reliability we bring to every project.

Measuring Aspheres in a 3D World

March 13, 2025
Learn about the cutting-edge techniques Lacroix Optics uses to measure aspheric lenses in 3D space for unparalleled accuracy and precision.

Voice your opinion!

To join the conversation, and become an exclusive member of Laser Focus World, create an account today!